Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc |
| |
Authors: | Benjamin P Fauber Gladys de Leon Boenig Brenda Burton Céline Eidenschenk Christine Everett Alberto Gobbi Sarah G Hymowitz Adam R Johnson Marya Liimatta Peter Lockey Maxine Norman Wenjun Ouyang Olivier René Harvey Wong |
| |
Institution: | 1. Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA;2. Argenta, Units 7–9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, UK |
| |
Abstract: | The structure–activity relationships of T0901317 analogs were explored as RORc inverse agonists using the principles of property- and structure-based drug design. An X-ray co-crystal structure of T0901317 and RORc was obtained and provided molecular insight into why T0901317 functioned as an inverse agonist of RORc; whereas, the same ligand functioned as an agonist of FXR, LXR, and PXR. The structural data was also used to design inhibitors with improved RORc biochemical and cellular activities. The improved inhibitors possessed enhanced selectivity profiles (rationalized using the X-ray crystallographic data) against other nuclear receptors. |
| |
Keywords: | RORc RORγ T0901317 X-ray structure IL-17 Inflammation Autoimmune |
本文献已被 ScienceDirect 等数据库收录! |
|